Autocrine TGFβ Is a Survival Factor for Monocytes and Drives Immunosuppressive Lineage Commitment.
Adenocarcinoma of Lung
/ etiology
Antigen Presentation
/ immunology
Autocrine Communication
Biomarkers
Cell Differentiation
/ immunology
Cell Survival
/ genetics
Dendritic Cells
/ immunology
Gene Expression Profiling
Humans
Immunomodulation
Monocytes
/ cytology
Myeloid-Derived Suppressor Cells
/ cytology
Signal Transduction
Transforming Growth Factor beta
/ genetics
Transforming Growth Factor beta1
/ metabolism
Journal
Cancer immunology research
ISSN: 2326-6074
Titre abrégé: Cancer Immunol Res
Pays: United States
ID NLM: 101614637
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
15
05
2018
revised:
06
08
2018
accepted:
07
12
2018
pubmed:
13
12
2018
medline:
9
4
2020
entrez:
13
12
2018
Statut:
ppublish
Résumé
Transforming growth factor β (TGFβ) is an effector of immune suppression and contributes to a permissive tumor microenvironment that compromises effective immunotherapy. We identified a correlation between
Identifiants
pubmed: 30538091
pii: 2326-6066.CIR-18-0310
doi: 10.1158/2326-6066.CIR-18-0310
pmc: PMC6828175
mid: NIHMS1041406
doi:
Substances chimiques
Biomarkers
0
Transforming Growth Factor beta
0
Transforming Growth Factor beta1
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
306-320Subventions
Organisme : NIH HHS
ID : DP5 OD023056
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016087
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA082103
Pays : United States
Organisme : NIH HHS
ID : S10 OD018040
Pays : United States
Informations de copyright
©2018 American Association for Cancer Research.
Références
Proc Natl Acad Sci U S A. 1987 Aug;84(16):5788-92
pubmed: 2886992
Nature. 2018 Feb 22;554(7693):544-548
pubmed: 29443960
Nature. 2007 Jun 21;447(7147):972-8
pubmed: 17538624
Bioinformatics. 2010 Sep 1;26(17):2176-82
pubmed: 20610611
Cytokine Growth Factor Rev. 2014 Aug;25(4):377-90
pubmed: 25200249
J Clin Invest. 2015 Sep;125(9):3356-64
pubmed: 26168215
Cell Rep. 2016 Dec 20;17(12):3219-3232
pubmed: 28009291
Clin Cancer Res. 2016 Dec 1;22(23):5661-5672
pubmed: 27178742
Oncogene. 2005 Aug 11;24(34):5278-86
pubmed: 16007221
Growth Factors. 2015 Apr;33(2):79-91
pubmed: 25586866
Cancer Res. 2015 Jun 1;75(11):2232-42
pubmed: 25858148
J Immunol. 2008 Oct 1;181(7):4666-75
pubmed: 18802069
J Mol Cell Biol. 2013 Jun;5(3):207-9
pubmed: 23532593
Science. 2015 Jul 10;349(6244):1259425
pubmed: 26160952
Nature. 2016 Nov 17;539(7629):443-447
pubmed: 27828943
J Exp Med. 2008 Sep 29;205(10):2235-49
pubmed: 18809714
Nat Rev Immunol. 2012 Jan 06;12(2):125-35
pubmed: 22222875
Cell. 2016 May 5;165(4):780-91
pubmed: 27153492
J Immunol. 2010 Aug 15;185(4):2273-84
pubmed: 20644162
Nat Methods. 2015 May;12(5):453-7
pubmed: 25822800
Nat Rev Immunol. 2009 Mar;9(3):162-74
pubmed: 19197294
Nat Med. 2015 Aug;21(8):938-945
pubmed: 26193342
J Immunol. 2007 Mar 1;178(5):2883-92
pubmed: 17312132
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Am J Respir Cell Mol Biol. 2002 Feb;26(2):224-30
pubmed: 11804874
J Cell Mol Med. 2005 Jan-Mar;9(1):59-71
pubmed: 15784165
J Immunol. 2006 Jul 1;177(1):216-26
pubmed: 16785517
Nature. 2018 Feb 22;554(7693):538-543
pubmed: 29443964
Cytometry A. 2012 Jun;81(6):467-75
pubmed: 22577098
J Transl Med. 2011 Jun 09;9:90
pubmed: 21658270
Cancer Immunol Res. 2017 Jan;5(1):3-8
pubmed: 28052991
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Cell. 2008 Jul 25;134(2):215-30
pubmed: 18662538
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Trends Immunol. 2002 Nov;23(11):549-55
pubmed: 12401408
Cancer Discov. 2014 Oct;4(10):1230-41
pubmed: 25084773
Nature. 2017 Mar 30;543(7647):728-732
pubmed: 28321130
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Genome Biol. 2014 Feb 03;15(2):R29
pubmed: 24485249
J Immunol. 2003 Apr 1;170(7):3806-11
pubmed: 12646647
Clin Cancer Res. 2015 Feb 1;21(3):553-60
pubmed: 25424852
Nat Med. 2015 Jul;21(7):677-87
pubmed: 26121197
Cancer Cell. 2013 Jun 10;23(6):768-83
pubmed: 23764001
Cancer Cell. 2009 Sep 8;16(3):183-94
pubmed: 19732719
Mol Cell Biol. 2009 Nov;29(22):6006-17
pubmed: 19752192
Mol Cell Biol. 2009 Jan;29(1):172-86
pubmed: 18955504
Cancer Immunol Res. 2016 Jul;4(7):592-9
pubmed: 27197061
Clin Cancer Res. 2011 Nov 1;17(21):6754-65
pubmed: 22028490
Cytokine Growth Factor Rev. 2017 Aug;36:5-15
pubmed: 28693973
J Immunol. 2012 Jun 1;188(11):5500-10
pubmed: 22544933
Nat Commun. 2016 Jul 06;7:12150
pubmed: 27381735
Curr Opin Pharmacol. 2009 Aug;9(4):470-81
pubmed: 19616475
Oncol Lett. 2011 Jul;2(4):583-589
pubmed: 22848232
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Nat Methods. 2015 Feb;12(2):115-21
pubmed: 25633503
Blood Cells Mol Dis. 2007 Nov-Dec;39(3):329-35
pubmed: 17659913
Stat Appl Genet Mol Biol. 2004;3:Article3
pubmed: 16646809
PLoS One. 2016 Oct 25;11(10):e0164514
pubmed: 27780254
Nat Rev Cancer. 2013 Nov;13(11):788-99
pubmed: 24132110
Nat Rev Drug Discov. 2012 Oct;11(10):790-811
pubmed: 23000686
Eur J Immunol. 2004 May;34(5):1342-50
pubmed: 15114667
Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):91-9
pubmed: 25835621
Nat Med. 2004 Jan;10(1):48-54
pubmed: 14702634
BMC Immunol. 2012 Jun 15;13:31
pubmed: 22703233
Cancer Res. 2012 Aug 15;72(16):4119-29
pubmed: 22693253
Trends Immunol. 2011 Jan;32(1):19-25
pubmed: 21067974